ACM
NBP

Ariose Capital Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Ariose Capital Management’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,363,515
Closed -$5.43M – 18
2025
Q4 		$5.43M Sell
1,363,515
-340,878
-20% -$1.51M 1.82% 10
2025
Q3 		$6.44M Buy
1,704,393
+1,607,938
+1,667% +$5.46M 2.16% 14
2025
Q2 		$233K Buy
+96,455
New +$131K 0.15% 18

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
AIHC Capital Management Central $120M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ariose Capital Management's NBP Position: Q1 2026 in Review

Ariose Capital Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026, closing a stake of 1,363,515 shares — an estimated $5.43M sold.

Ariose Capital Management first reported a position in NBP in Q2 2025 and held it in 3 quarters. The position peaked at $6.44M in Q3 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Ariose Capital Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Ariose Capital Management sold 1,363,515 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $5.43M.
  • Ariose Capital Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2025 and held it in 3 quarters.
  • Ariose Capital Management's NovaBridge Biosciences American Depositary Shares position peaked at $6.44M in Q3 2025.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Ariose Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.